BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 17373308)

  • 1. Euthyroid Graves' ophthalmopathy in a child.
    Peter S
    West Indian Med J; 2006 Oct; 55(5):360. PubMed ID: 17373308
    [No Abstract]   [Full Text] [Related]  

  • 2. Euthyroid Graves' ophthalmopathy with negative autoantibodies.
    Cakir M
    J Natl Med Assoc; 2005 Nov; 97(11):1547-9. PubMed ID: 16334503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Childhood Graves' ophthalmopathy: results of a European questionnaire study.
    Krassas GE; Segni M; Wiersinga WM
    Eur J Endocrinol; 2005 Oct; 153(4):515-21. PubMed ID: 16189172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orbital pseudotumor: a differential diagnosis of Graves' ophthalmopathy.
    Caminha LS; Pinto ER; Sousa PA; Oliveira RA; Conceiçao FL; Vaisman M
    Arq Bras Endocrinol Metabol; 2011 Feb; 55(1):85-8. PubMed ID: 21468526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unilateral optic neuropathy as the initial manifestation of euthyroid Graves' disease.
    Arslan E; Yavaşoğlu I; Cildağ BM; Kocatürk T
    Intern Med; 2009; 48(22):1993-4. PubMed ID: 19915303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TSH receptor antibody titers measured with a third-generation assay did not reflect the activity of Graves' ophthalmopathy in untreated Japanese Graves' disease patients.
    Mukasa K; Yoshimura Noh J; Kouzaki A; Ohye H; Kunii Y; Watanabe N; Yoshihara A; Matsumoto M; Suzuki M; Ito K
    Endocr J; 2016; 63(2):151-7. PubMed ID: 26581710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy.
    Prummel MF; Wiersinga WM; Mourits MP; Koornneef L; Berghout A; van der Gaag R
    Arch Intern Med; 1990 May; 150(5):1098-101. PubMed ID: 1691908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies targeting the calcium binding skeletal muscle protein calsequestrin are specific markers of ophthalmopathy and sensitive indicators of ocular myopathy in patients with Graves' disease.
    Gopinath B; Musselman R; Beard N; El-Kaissi S; Tani J; Adams CL; Wall JR
    Clin Exp Immunol; 2006 Jul; 145(1):56-62. PubMed ID: 16792674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Latanoprost is effective in reducing high intraocular pressure associated with Graves' ophthalmopathy.
    Gumińska M; Kłysik A; Siejka A; Jurowski P
    Klin Oczna; 2014; 116(2):89-93. PubMed ID: 25345284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigations of ocular changes, extraocular muscle thickness, and eye movements in Graves' ophthalmopathy.
    Jankauskiene J; Imbrasiene D
    Medicina (Kaunas); 2006; 42(11):900-3. PubMed ID: 17172791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of Graves' ophthalmopathy.
    Wiersinga WM
    Nat Clin Pract Endocrinol Metab; 2007 May; 3(5):396-404. PubMed ID: 17452966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Graves' disease and thyroid associated ophthalmopathy following radioiodine therapy in euthyroid multinodular goiter.
    Munigoti S; Samat A; Keston Jones M
    Thyroid; 2008 May; 18(5):585. PubMed ID: 18466082
    [No Abstract]   [Full Text] [Related]  

  • 13. Hyperthyroidism and severity of orbital disease do not change the central corneal thickness in Graves' ophthalmopathy.
    Konuk O; Aktas Z; Aksoy S; Onol M; Unal M
    Eur J Ophthalmol; 2008; 18(1):125-7. PubMed ID: 18203097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid ophthalmopathy.
    Shah Y
    J Assoc Physicians India; 2011 Jan; 59 Suppl():60-5. PubMed ID: 21819005
    [No Abstract]   [Full Text] [Related]  

  • 15. [Thyroid-associated ophthalmopathy: case report of a euthyroid patient].
    Kabasawa C; Maruyama K; Kobayashi M; Shimizu Y; Iwata M; Uchiyama S
    Brain Nerve; 2010 Jul; 62(7):804-5. PubMed ID: 20675885
    [No Abstract]   [Full Text] [Related]  

  • 16. Advances in treatment of active, moderate-to-severe Graves' ophthalmopathy.
    Wiersinga WM
    Lancet Diabetes Endocrinol; 2017 Feb; 5(2):134-142. PubMed ID: 27346786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Graves' Ophthalmopathy in a Paediatric Population.
    Sadeghi Y; Obéric A; Theintz G; Hamédani M
    Klin Monbl Augenheilkd; 2017 Apr; 234(4):591-594. PubMed ID: 28329893
    [No Abstract]   [Full Text] [Related]  

  • 18. [Euthyroid Graves' disease: a case report].
    Hornez N; Morell-Dubois S; Woillez JP; Queyrel V; Charlanne H; Launay D; Lambert M; Hachulla E; Wemeau JL; Hatron PY
    Rev Med Interne; 2009 Nov; 30(11):988-90. PubMed ID: 19299047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Four patients with hypothyroid Graves' disease.
    Starrenburg-Razenberg AJ; Castro Cabezas M; Gan IM; Njo TL; Rietveld AP; Elte JW
    Neth J Med; 2010 Apr; 68(4):178-80. PubMed ID: 20421660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optical Coherence Tomography Thickness Measurements of the Extraocular Rectus Muscle Tendons in Graves' Ophthalmopathy.
    De-Pablo-Gómez-de-Liaño L; Fernández-Vigo JI; Ventura-Abreu N; Troyano-Rivas J; Niño-Rueda C; Romo-López Á; Gómez-de-Liaño R
    J Pediatr Ophthalmol Strabismus; 2018 Nov; 55(6):356-362. PubMed ID: 30160297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.